MMRGlobal 2014 "This Is Our Year" Letter to Shareholders
LOS ANGELES, CA--(Marketwired - Apr 1, 2014) - MMRGlobal, Inc. (OTCQB: MMRF)
As another year of reporting has ended with the filing of our Annual Report, I wanted to take a few minutes discussing why we believe 2014 is "our year." MMR's primary business is to offer and sell Personal Health Records ("PHRs") and license our patented health information technologies that help make them work. Starting January this year, at least fifty percent of all patients seen by eligible providers must have the ability to view, download and transmit their health information within four days after the records are available to the doctor or within 36 hours after a hospital discharge. As a leading provider of Personal Health Records, this means your Company is in the right place at the best of times.
Based on Meaningful Use requirements under the stimulus bill's HITECH Act, we got ready for prime time by investing millions of dollars in patents, intellectual property and technology preparing for 2014, the year of Transformation of Healthcare. And so did the U.S. government, which spent hundreds of millions of dollars, in fact more than $379 million, educating consumers on the health insurance marketplace and the Affordable Care Act ("ACA"), and the importance of having a Personal Health Record.
And we were right to invest. Seven million people have already enrolled in ACA through HealthCare.gov and it is expected that over 30 million more will ultimately be covered. Those 30 million and the rest of the insured population are being offered PHRs and other health & wellness tools as part of the everyday office routine in an effort to deliver better patient outcomes at reduced costs.
And when providers offer PHRs as part of the office routine, MMR stands to benefit.
Wall Street has also been right to invest in health information technology ("HIT") companies. In fact, less than two weeks ago Castlight Health Systems, a company that sells products and services to patients and employers similar to MMR, went public on the NYSE. Castlight debuted with $13 million in sales, trading at more than a 150 times revenue or in excess of two billion dollars in market cap. This clearly demonstrates the strength of the equity market for HIT companies like MMR.